Literature DB >> 9203959

The serum resistance of malaria-infected erythrocytes.

Y Kawamoto1, K Kojima, Y Hitsumoto, H Okada, V M Holers, A Miyama.   

Abstract

IgG and IgM antibodies were detected on non-parasitized as well as parasitized erythrocytes (E) from mice surviving over 15 days after infection with rodent malaria, Plasmodium berghei, whereas C3 was detected exclusively on parasitized E. Parasitized E, however, were quite resistant to the haemolytic activity of guinea pig complement and effectively inactivated human C3b to iC3b on their surface. Similarly, parasitized E were extremely resistant to homologous complement as assessed by haemolysis and C3 binding even when regulatory proteins (decay-accelerating factor, DAF; complement receptor related gene y, Crry; heat-stable antigen, HSA) were blocked with specific antibodies. DAF and Crry were equally expressed on both normal E and parasitized E from mice within a week post-infection; therefore, molecules that inhibit the haemolysis or C3 binding of parasitized E appear to be independent of DAF and Crry. Unexpectedly, the molecular forms of HSA and DAF in parasitized erythrocyte membranes were found to be different from those of normal erythrocyte membranes: DAF was detected as three bands (85,000, 64,000 and 30,000 MW) by immunoblotting. HSA was detected as more highly glycosylated forms than normal HSA. These alterations of DAF and HSA could be explained by the modification of membrane proteins and polysaccharides induced by parasitization, and we hypothesize that these changes of membranes or membrane proteins are involved in the resistance of parasitized E against homologous complement.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9203959      PMCID: PMC1364028          DOI: 10.1046/j.1365-2567.1997.00188.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  19 in total

Review 1.  The evolution of mouse and human complement C3-binding proteins: divergence of form but conservation of function.

Authors:  V M Holers; T Kinoshita; H Molina
Journal:  Immunol Today       Date:  1992-06

Review 2.  The control of homologous lysis.

Authors:  P J Lachmann
Journal:  Immunol Today       Date:  1991-09

3.  Characterization of three monoclonal antibodies against C3 with selective specificities.

Authors:  K Iida; K Mitomo; T Fujita; N Tamura
Journal:  Immunology       Date:  1987-11       Impact factor: 7.397

4.  Immune hemolysis: a simplified method for the preparation of EAC'4 with guinea pig or with human complement.

Authors:  T Borsos; H J Rapp
Journal:  J Immunol       Date:  1967-08       Impact factor: 5.422

5.  Complement activation by the surface of Plasmodium falciparum infected erythrocytes.

Authors:  H A Stanley; J T Mayes; N R Cooper; R T Reese
Journal:  Mol Immunol       Date:  1984-02       Impact factor: 4.407

6.  Cryoglobulins, circulating immune complexes, and complement activation in cerebral malaria.

Authors:  C Adam; M Géniteau; M Gougerot-Pocidalo; P Verroust; J Lebras; C Gibert; L Morel-Maroger
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

7.  Inhibition of homologous complement activation by the heat-stable antigen.

Authors:  Y Hitsumoto; H Ohnishi; A Nakano; F Hamada; S Saheki; N Takeuchi
Journal:  Int Immunol       Date:  1993-07       Impact factor: 4.823

8.  Mouse Crry/p65. Characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF.

Authors:  B Li; C Sallee; M Dehoff; S Foley; H Molina; V M Holers
Journal:  J Immunol       Date:  1993-10-15       Impact factor: 5.422

9.  Murine membrane inhibitor of complement which accelerates decay of human C3 convertase.

Authors:  Y Kameyoshi; M Matsushita; H Okada
Journal:  Immunology       Date:  1989-12       Impact factor: 7.397

10.  Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein.

Authors:  Y U Kim; T Kinoshita; H Molina; D Hourcade; T Seya; L M Wagner; V M Holers
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

View more
  2 in total

1.  Complement contributes to protective immunity against reinfection by Plasmodium chabaudi chabaudi parasites.

Authors:  P R Taylor; E Seixas; M J Walport; J Langhorne; M Botto
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

2.  Increased expression of complement regulators CD55 and CD59 on peripheral blood cells in patients with EAHEC O104:H4 infection.

Authors:  Werner Dammermann; Pim Schipper; Sebastian Ullrich; Katharina Fraedrich; Julian Schulze Zur Wiesch; Thorben Fründt; Gisa Tiegs; Ansgar Lohse; Stefan Lüth
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.